Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro

24 Jan 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Pancreatic and Hepatic Oncology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28120247
DOI: 10.1007/s11626-016-0126-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitroPMID 28120247Read ↗

Colorectal cancer heterogeneity and targeted therapy: Clinical implications, challenges and solutions for treatment resistanceSemantic proximity Read ↗

Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technologySemantic proximity Read ↗

Intratumoral functional heterogeneity and chemotherapy.Semantic proximity Read ↗

Colorectal Cancer Cell Lines Lack the Molecular Heterogeneity of Clinical Colorectal TumorsSemantic proximity Read ↗

From tumour heterogeneity to advances in precision treatment of colorectal cancerSemantic proximity Read ↗

Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugsSemantic proximity Read ↗

Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroidsSemantic proximity Read ↗

Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D culturesSemantic proximity Read ↗

Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug ResponsesSemantic proximity Read ↗

A Tale of Two Cell Lines: Characterization of differential efficacy of small molecule drugs cediranib and NU-7441 on primary vs. metastatic colorectal cancerSemantic proximity Read ↗

Cell Line Models of Molecular Subtypes of Colorectal Cancer.Semantic proximity Read ↗

Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.